Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation

被引:28
|
作者
Wingate, Jonathan T. [1 ]
Brandenberger, Jared [2 ]
Weiss, Andrew [3 ]
Scovel, Lauren G. [2 ]
Kuhr, Christian S. [2 ]
机构
[1] Madigan Army Med Ctr, Dept Urol, Tacoma, WA 98431 USA
[2] Virginia Mason Med Ctr, Dept Urol & Renal Transplantat, Seattle, WA 98101 USA
[3] Virginia Mason Med Ctr, Dept Nephrol & Renal Transplantat, Seattle, WA 98101 USA
关键词
bacteriuria; BK nephropathy; BK viremia; ureteral stent; URINARY-TRACT-INFECTION; SINGLE-CENTER EXPERIENCE; UROLOGICAL COMPLICATIONS; RENAL-TRANSPLANTATION; NEPHROPATHY; IMPACT; RECIPIENTS; VIRUS;
D O I
10.1111/tid.12644
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesUreteral stents are used in kidney transplantation (KTX) to decrease post-operative complications, but they are associated with BK polyomavirus viremia (BKV). Our primary outcome was to determine the association between ureteral stent duration and BKV. Secondary outcome measures were the association between bacteriuria and stent duration or use of ureteral stent strings. MethodsBetween January 2010 and January 2015, 403 patients underwent KTX at the Virginia Mason Medical Center and met inclusion criteria. Stent duration was classified as short (<3weeks) or long (>3weeks). Multivariate logistic regression models were created to assess for factors associated with BKV. The covariates in the BKV model were chosen a priori based on stent duration and risk factors previously described in the literature. ResultsUreteral stents were placed in 304 (75.4%) transplants. Stent strings were left attached in 166 (54.6%) patients. On multivariate analyses, long stent duration was significantly associated with increased risk of BKV compared with no stent (odds ratio [OR] 1.92, P=.044, 95% confidence interval [CI] 1.04-3.74). Short stent duration was not associated with BKV. Sixty-two (15.4%) patients had bacteriuria. Bacteriuria was associated with female gender (OR 2.77, P<.001, 95% CI 1.58-4.95), and there was a dose-dependent effect with stent duration compared with no stentshort duration (OR 2.46, P=.049, 95% CI 1.05-6.49) and long duration (OR 3.58, P=.004, 95% CI 1.58-9.25). Stent strings were not associated with either complication. ConclusionsThe association between ureteral stents and BKV may be dose dependent.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?
    Rodriguez-Goncer, Isabel
    Ruiz-Ruigomez, Maria
    Lopez-Medrano, Francisco
    Corbella, Laura
    Polanco, Natalia
    Gonzalez Monte, Esther
    San Juan, Rafael
    Ruiz-Merlo, Tamara
    Parra, Patricia
    Folgueira, Lola
    Andres, Amado
    Maria Aguado, Jose
    Fernandez-Ruiz, Mario
    TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [42] BK virus allograft nephropathy and ureteral stent placement in pediatric kidney transplantation.
    Araya, Carlos E.
    Wadsworth, Christopher
    Hou, Wei
    Li, Qin
    Bispham, Jacky-Lynn
    McKinney, Michael C.
    Dharnidharka, Vikas R.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 85 - 85
  • [43] Prevalence, Risk Factors, Treatment, and Overall Impact of BK Viremia on Kidney Transplantation
    Malik, Omar
    Saleh, Sherif
    Suleiman, Belal
    Ashqar, Bilal
    Maibam, Amita
    Yaseen, Maria
    Elrefaei, Amro
    Hines, Abigail
    Cornea, Virgilius
    El-Husseini, Amr
    Mei, Xiaonan
    Gedaly, Roberto
    Castellanos, Ana Lia
    Waid, Thomas
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (06) : 1801 - 1809
  • [44] PREOPERATIVE ANTIBODY TITER AGAINST BK POLYOMAVIRUS MAY PREDICT BK POLYOMAVIRUS-ASSOCIATED NEPHROPATHY AFTER KIDNEY TRANSPLANTATION
    Saito, Mitsuru
    Satoh, Shigeru
    Saito, Takuro
    Yamamoto, Ryohei
    Nara, Taketoshi
    Chiba, Syuji
    Kanda, Sohei
    Numakura, Kazuyuki
    Narita, Shintaro
    Inoue, Takamitsu
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1039 - E1040
  • [45] BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation
    Ahlenstiel-Grunow, Thurid
    Sester, Martina
    Sester, Urban
    Hirsch, Hans H.
    Pape, Lars
    TRANSPLANTATION, 2020, 104 (11) : 2393 - 2402
  • [46] Preoperative Antibody Titer Against BK Polyomavirus May Predict BK Polyomavirus-Associated Nephropathy after Kidney Transplantation
    Saito, M.
    Satoh, S.
    Numakura, K.
    Sagehashi, R.
    Yamamoto, R.
    Koizumi, A.
    Nara, T.
    Narita, S.
    Habuchi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 815 - 815
  • [47] BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition
    Johannes Jacobi
    Antonina Prignitz
    Maike Büttner
    Klaus Korn
    Alexander Weidemann
    Karl F Hilgers
    Katharina Heller
    Joachim Velden
    Antje Knöll
    Bernd Wullich
    Christoph May
    Kai-Uwe Eckardt
    Kerstin U Amann
    BMC Nephrology, 14
  • [48] Dynamic risk prediction of BK polyomavirus reactivation after renal transplantation
    Fang, Yiling
    Zhang, Chengfeng
    Wang, Yuchen
    Yu, Zhiyin
    Wu, Zhouting
    Zhou, Yi
    Yan, Ziyan
    Luo, Jia
    Xia, Renfei
    Zeng, Wenli
    Deng, Wenfeng
    Xu, Jian
    Chen, Zheng
    Miao, Yun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] BK VIREMIA AND POLYOMAVIRUS NEPHROPATHY IN 352 KIDNEY TRANSPLANTS; RISK FACTORS AND POTENTIAL ROLE OF MTOR INHIBITION
    Jacobi, J.
    Prignitz, A.
    Buettner, M.
    Korn, K.
    Weidemann, A.
    Hilgers, K.
    Heller, K.
    Velden, J.
    Knoell, A.
    Wullich, B.
    May, C.
    Eckardt, K. -U.
    Amann, K.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 41 - 41
  • [50] Evaluation of a Preemptive Strategy for BK Polyomavirus-Associated Nephropathy Based on Prospective Monitoring of BK Viremia: A Kidney Transplantation Center Experience
    Renoult, E.
    Coutlee, F.
    Paquet, M.
    St Louis, G.
    Girardin, C.
    Fortin, M. -C.
    Cardinal, H.
    Levesque, R.
    Schuerch, W.
    Latour, M.
    Barama, A.
    Hebert, M. -J.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4083 - 4087